Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Chemistry & Biology|February 27, 2013
Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agentsHao Wang, Charles J Gill, Sang H Lee, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|July 22, 2024
Recombinant Antibody-Producing Stable CHOK1 Pool Stability StudyBailin Tu, Zhihong Lin, Jeff Moore, et al.
Parkinsonism & Related Disorders|August 30, 2008
Dopamine beta-hydroxylase -1021C>T association and Parkinson's diseaseOwen A Ross, Michael G Heckman, Alexandra I Soto, et al.
Parkinsonism & Related Disorders|September 16, 2008
Genetic variation of Omi/HtrA2 and Parkinson's diseaseOwen A Ross, Alexandra I Soto, Carles Vilariño-Güell, et al.
European Journal of Neurology|August 14, 2009
Calbindin-1 association and Parkinson's diseaseA I Soto-Ortolaza, B Behrouz, C Wider, et al.
European Journal of Human Genetics : EJHG|October 16, 2008
Fine-mapping and candidate gene investigation within the PARK10 locusKristoffer Haugarvoll, Mathias Toft, Lisa Skipper, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Annals of Neurology|February 2, 2006
UCHL-1 is not a Parkinson's disease susceptibility geneDaniel G Healy, Patrick M Abou-Sleiman, Juan P Casas, et al.
The Lancet. Rheumatology|June 30, 2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELYMark D Russell, Andrea Schaffer, Zijing Yang, et al.
BMJ (Clinical Research Ed.)|January 21, 2026
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELYMark D Russell, Andrea Schaffer, Katie Bechman, et al.
Pageof 12